Radcliffe EM, Baumgartner AJ, Kern DS, Al Borno M, Ojemann S, Kramer DR, Thompson JA. Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson's disease. J Neurophysiol. 2023 Jun 1;129(6):1492-1504. PubMed PMID: 37198135
Memon AA, Edney BS, Baumgartner AJ, Gardner AJ, Catiul C, Irwin ZT, Joop A, Miocinovic S, Amara AW. Effects of deep brain stimulation on quantitative sleep electroencephalogram during non-rapid eye movement in Parkinson's disease. Front Hum Neurosci. 2023;17:1269864. PubMed PMID: 37810765
Baker S, Fenstermacher E, Davis RA, Kern DS, Thompson JA, Felsen F, Baumgartner AJ. Ethical considerations in closed loop deep brain stimulation. Deep Brain Stimulation. 2023; doi: 10.1016/j.jdbs.2023.11.001
Thompson JA, Ojemann SG, Kramer DR, Hirt L, Radcliffe E, Case M, Zarns C, Holt-Becker A, Raike R, Baumgartner AJ, Kern DS. Pilot study to investigate the use of monopolar sensing to improve the efficiency of DBS programming in Parkinson’s disease. Poster presented at: International Congress of Parkinson’s Disease and Movement Disorders. 2023 August 29; Copenhagen, DK
Thompson JA, Hirt L, Kern DS, Baumgartner AJ. Characterization of at-home sleep macrostructure in Parkinson disease using a wearable sleep monitoring device. Poster presented at: International Congress of Parkinson’s Disease and Movement Disorders. 2023 August 28; Copenhagen, DK
Hirt L, Kern DS, Thompson JA, Baumgartner AJ. The association between sleep quality and subthalamic nucleus volume of tissue activation in Parkinson’s disease. Poster presented at: 3rd Joint Congress of the International Neuromodulation Society European Chapters (e-INS 2023). 2023 September 1; Hamburg, DE
Baumgartner AJ, Thompson JA, Kern DS, Ojemann SG. Novel targets in deep brain stimulation for movement disorders. Neurosurg Rev. 2022 Aug;45(4):2593-2613. PubMed PMID: 35511309
Baumgartner AJ, Adkins M, Bainbridge J, Leehey MA. Acute akathisia following initiation of opicapone: A case report. Clin Park Relat Disord. 2022;7:100154. PubMed PMID: 35898798
Kern D, Korsmo M, Baumgartner AJ, Kramer D, Ojemann S, Case M, Holt-Becker AB, Raike R, Thompson JA. Methylphenidate effects on a clinically informative oscillatory signal within the subthalamic nucleus in Parkinson's disease during deep brain stimulation programming. Brain Stimul. 2022 May-Jun;15(3):747-749. PubMed PMID: 35526817
Hirt L, Baumgartner AJ, Kern DS, Kramer D, Ojemann SG, Thompson JA. Targeted versus actual stimulated areas in deep brain stimulation surgery for essential tremor. Poster presented at: University of Colorado Neurosurgery Research Symposium. 2022 May 3; Aurora, CO.
Baumgartner AJ, Kushida CA, Summers MO, Kern DS, Abosch A, Thompson JA. Basal Ganglia Local Field Potentials as a Potential Biomarker for Sleep Disturbance in Parkinson's Disease. Front Neurol. 2021;12:765203. PubMed PMID: 34777232
Baumgartner AJ, Press DZ, Simon DK. The Relationship Between Olfactory Dysfunction and Constipation in Early Parkinson's Disease. Mov Disord. 2021 Mar;36(3):781-782. PubMed PMID: 33404111
Baumgartner AJ, Hirt L, Kern DS, Thompson JA. Naturalistic sleep in Parkinson’s disease assessed by actigraphy and direct recordings of the subthalamic nucleus. Poster presented at: Neuroscience 2021. 50th Annual Meeting of the Society for Neuroscience. 2021 November 8-11.
Rossi KC, Baumgartner AJ, Goldenholz SR, Goldenholz DM. Recognizing and refuting the myth of tongue swallowing during a seizure. Seizure. 2020 Dec;83:32-37. PubMed PMID: 33080482
Baumgartner A, Quesenberry PJ. A Unique Neuropsychiatric Syndrome in Variant Hereditary Coproporphyria: Case Report and Review of the Literature. J Hematol. 2017 Mar;6(1):21-24. PubMed PMID: 32300387
Baumgartner A, Anthony D. The Decline of the Autopsy in Rhode Island and Nationwide: Past Trends and Future Directions. R I Med J (2013). 2016 Oct 4;99(10):36-38. PubMed PMID: 27706277
Baumgartner A, Coleman S, Swanson B. The cost of the sword: escape performance in male swordtails. PLoS One. 2011 Jan 6;6(1):e15837. PubMed PMID: 21253013
Clinical Interests
I evaluate and treat patients with Parkinson disease and other forms of parkinsonism, tremor, dystonia, ataxia, myoclonus, chorea, and tics. I specialize in the treatment of movement disorders with deep brain stimulation and other advanced therapies.
Public Speaking Yes
General Information
Medical Schools:
MD, The Warren Alpert Medical School of Brown University
(2016)
Undergraduate Schools:
BA, Gonzaga University (WA)
(2011)
Internships:
Beth Israel Deaconess Medical Center/Harvard Medical School Program
(2017)
Residency Programs:
Beth Israel Deaconess Medical Center/Harvard Medical School Program, Chief Resident, Neurology (2020)